COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,627 Articles (22,913 medRxiv, 8,714 bioRxiv)

Most recent first Previous |  Page 508: Articles 5071-5080  | Next

Predicting the feasibility of targeting a conserved region on the S2 domain of the SARS-CoV-2 spike protein
Garg, P., Hsueh, S. C. C., Plotkin, S. S.
10.1101/2023.03.05.531227 — Posted: 2023-03-06
Tau protein aggregation associated with SARS-CoV-2 main protease
Eberle, R. J., Coronado, M. A., Gering, I., Korostov, K., Stefanski, A., Stuehler, K., Kraemer-Schulien, V., Bloemeke, L., Bannach, O., Willbold, D.
10.1101/2023.03.04.531078 — Posted: 2023-03-06
Modelling the association between neutralizing antibody levels and SARS-CoV-2 viral dynamics : implications to define correlates of protection against infection
Lingas, G., Planas, D., Pere, H., Duffy, D., Staropoli, I., Porrot, F., Guivel-Benhassine, F., Chapuis, N., Gobeaux, C., Veyer, D., Delaugerre, C., Le Goff, J., Getten, P., Hadjadj, J., Bellino, A., Parfait, B., Treluyer, J.-M., Schwartz, O., Guedj, J., Kerneis, S., Terrier, B.
10.1101/2023.03.05.23286816 — Posted: 2023-03-06
Post-COVID-19 syndrome and related dysautonomia reduce quality of life, and increase anxiety and depressive symptoms: evidence from Greece
Galanis, P. A., KATSIROUMPA, A., Vraka, I., Kosiara, K., Konstantakopoulou, O., Katsoulas, T., Gallos, P., Kaitelidou, D.
10.1101/2023.03.05.23286811 — Posted: 2023-03-06
Real-time Dissection and Forecast of Infection Dynamics during a Pandemic
Schulz, S., Pastor, R., Koyuncuoglu, C., Crawford, F. W., Zernick, D., Karch, A., Rüdiger, S.
10.1101/2023.03.02.23286502 — Posted: 2023-03-06
Spatially-resolved wastewater-based surveillance enables COVID-19 case localization across a university campus, and confirms lower SARS-CoV-2 RNA burden relative to the surrounding community
Lee, J., Acosta, N., Waddell, B., Du, K., Xiang, K., Van Doorn, J., Low, K., Bautista, M., McCalder, J., Dai, X., Lu, X., Chekouo, T., Pradhan, P., Sedaghat, N., Papparis, C., Beaudet, A. B., Chen, J., Chan, L., Vivas, L., Westlund, P., Bhatnagar, S., Stefani, S., Visser, G., Cabaj, J., Achari, G., Clark, R., Hrudey, S., Lee, B., Pang, X., Webster, B., Ghali, W. A., Buret, A. G., Williamson, T., Southern, D., Meddings, J., Frankowski, K., Hubert, C., Parkins, M.
10.1101/2023.03.03.23286756 — Posted: 2023-03-06
Improving the representativeness of UKs national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Pouwels, K. B., Eyre, D. W., House, T., Aspey, B., Matthews, P. C., Stoesser, N., Newton, J., Diamond, I., Studley, R., Taylor, N., Bell, J., Farrar, J., Kolenchery, J., Marsden, B., Hoosdally, S., Jones, Y., Stuart, D., Crook, D., peto, t. E., Walker, A. S., COVID-19 Infection Survey Team
10.1101/2023.02.26.23286474 — Posted: 2023-03-06
Impact of COVID-19 pandemic on the etiology and characteristics of community-acquired pneumonia among children requiring bronchoalveolar lavage in northern China
Liu, R., Zhang, Y., Lu, Z., Shen, C., Wang, J., Zhao, Q., Hou, T., Niu, F., Kong, Q., Ning, J., Yang, L.
10.1101/2023.03.02.23286686 — Posted: 2023-03-05
Bivalent booster effectiveness against severe COVID-19 outcomes in Finland, September 2022 - January 2023
Poukka, E., Goebeler, S., Nohynek, H., Leino, T., Baum, U.
10.1101/2023.03.02.23286561 — Posted: 2023-03-05
Molnupiravir's real-world effectiveness in COVID-19 non-hospitalized patients at high risk of severe disease: a single-center study
Gmizic, I., Todorovic, N., Sabanovic, M., Kekic, N., Boskovic, N., Milosevic, I., Stevanovic, G.
10.1101/2023.03.03.23286761 — Posted: 2023-03-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).